Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern recognition and uptake pathways on dendritic cells and B cells refer to the integrated biological systems used by professional antigen-presenting cells (APCs) to sense and internalize pathogens and danger signals (Mellman and Steinman, 2001). These pathways are primarily mediated by a variety of germline-encoded Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and scavenger receptors, which identify conserved molecular patterns known as PAMPs and DAMPs (Iwasaki and Medzhitov, 2004). Upon ligand binding, these receptors trigger intracellular signaling cascades and uptake mechanisms such as phagocytosis and receptor-mediated endocytosis, facilitating the processing of antigens for presentation on MHC molecules. B cells also utilize these pathways, often in synergy with B-cell receptor (BCR) signaling, to enhance their capacity for antigen presentation and to drive antibody production (Bekeredjian-Ding and Jego, 2009). These pathways are critical therapeutic targets; for example, TLR agonists like imiquimod and monophosphoryl lipid A are employed as vaccine adjuvants or immunotherapies to stimulate robust immune responses against infections and malignancies. However, the overactivation or dysregulation of these pathways can lead to severe safety concerns, such as cytokine release syndrome or the development of autoimmune diseases, requiring precise pharmacological control.
Activation of pattern recognition receptors (PRRs) and endocytic machinery to promote antigen internalization, processing, and presentation, thereby initiating or modulating adaptive immune responses.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern recognition and uptake pathways on dendritic cells and B cells.